1. Home
  2. SSP vs ACTU Comparison

SSP vs ACTU Comparison

Compare SSP & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • ACTU
  • Stock Information
  • Founded
  • SSP 1878
  • ACTU 2015
  • Country
  • SSP United States
  • ACTU United States
  • Employees
  • SSP N/A
  • ACTU N/A
  • Industry
  • SSP Broadcasting
  • ACTU
  • Sector
  • SSP Industrials
  • ACTU
  • Exchange
  • SSP Nasdaq
  • ACTU NYSE
  • Market Cap
  • SSP 158.9M
  • ACTU 162.1M
  • IPO Year
  • SSP 1988
  • ACTU 2024
  • Fundamental
  • Price
  • SSP $1.79
  • ACTU $7.69
  • Analyst Decision
  • SSP Buy
  • ACTU
  • Analyst Count
  • SSP 2
  • ACTU 0
  • Target Price
  • SSP $5.75
  • ACTU N/A
  • AVG Volume (30 Days)
  • SSP 462.0K
  • ACTU 20.8K
  • Earning Date
  • SSP 02-27-2025
  • ACTU 03-04-2025
  • Dividend Yield
  • SSP N/A
  • ACTU N/A
  • EPS Growth
  • SSP N/A
  • ACTU N/A
  • EPS
  • SSP N/A
  • ACTU N/A
  • Revenue
  • SSP $2,397,162,000.00
  • ACTU N/A
  • Revenue This Year
  • SSP $10.38
  • ACTU N/A
  • Revenue Next Year
  • SSP N/A
  • ACTU N/A
  • P/E Ratio
  • SSP N/A
  • ACTU N/A
  • Revenue Growth
  • SSP 1.66
  • ACTU N/A
  • 52 Week Low
  • SSP $1.68
  • ACTU $5.51
  • 52 Week High
  • SSP $5.12
  • ACTU $11.73
  • Technical
  • Relative Strength Index (RSI)
  • SSP 42.11
  • ACTU N/A
  • Support Level
  • SSP $1.73
  • ACTU N/A
  • Resistance Level
  • SSP $2.02
  • ACTU N/A
  • Average True Range (ATR)
  • SSP 0.13
  • ACTU 0.00
  • MACD
  • SSP 0.00
  • ACTU 0.00
  • Stochastic Oscillator
  • SSP 20.69
  • ACTU 0.00

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: